NIH Reporter #5R21EY035436-03

R&D for Multiplexed Sensing and Control of Neuromodulators in the Awake Brain

This opportunity is issued by the National Eye Institute (NEI) in partnership with Beth Israel Deaconess Medical Center for research and development in neuroscience. - Government Buyer: - National Eye Institute (NEI), part of the National Institutes of Health (NIH) - Collaboration with Beth Israel Deaconess Medical Center, Boston, MA - Products/Services Requested: - Research and development services focused on multiplexed sensing and control of neuromodulatory signals (e.g., vasopressin, oxytocin, dopamine, serotonin) in the awake brain - Emphasis on advanced imaging and closed-loop control methods - Application in animal models - OEMs and Vendors: - No specific OEMs or vendors are named in the solicitation - Unique or Notable Requirements: - Development of real-time monitoring and manipulation tools for neuromodulators - Open to qualified research organizations - No unique license or classification requirements specified

Description

This grant opportunity supports research on multiplexed sensing and control of neuromodulatory signals in the brain using advanced imaging techniques and closed-loop control methods. The project aims to develop tools for real-time monitoring and manipulation of neuromodulators such as vasopressin, oxytocin, dopamine, serotonin, and others in awake animal models. The research is conducted by Beth Israel Deaconess Medical Center in Boston, MA, under the National Eye Institute (NEI). The solicitation involves research and development work.

View original listing